Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989553661> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W1989553661 endingPage "588" @default.
- W1989553661 startingPage "579" @default.
- W1989553661 abstract "Background:The potent inhaled corticosteroid, fluticasone propionate (fluticasone), and the long-acting β2-agonist with a rapid onset of action, formoterol fumarate (formoterol), have now been combined in a single aerosol inhaler, fluticasone/formoterol (flutiform). This study investigated the efficacy and safety of fluticasone/formoterol combination therapy compared with its individual components administered concurrently via two separate inhalers.Methods:Patients ≥12 years (N = 210) with mild to moderate–severe persistent, reversible asthma were evenly randomised to 12 weeks of treatment (b.i.d.) with fluticasone/formoterol combination therapy (100/10 μg b.i.d. or 250/10 μg b.i.d.) or fluticasone plus formoterol (Flixotide Evohaler, pMDI, Flovent [HFA]; Foradil, DPI, Foradil Aerolizer) administered concurrently (fluticasone + formoterol; 100 μg + 12 μg b.i.d. or 250 μg + 12 μg b.i.d.) in an open-label, parallel-group, multicentre study. The primary objective of this study was to show non-inferiority of fluticasone/formoterol compared with fluticasone + formoterol based on mean post-dose FEV1.Results:The mean FEV1 30–60 minutes post-dose on Day 84 was approximately 2.6 L in both the fluticasone/formoterol combination and the fluticasone + formoterol treatment groups (per protocol sets; treatment difference least squares (LS) mean: −0.03 L; 95% CI: −0.148, 0.081). The lower limit of the 95% CI (−0.148 L) was above the non-inferiority threshold of ≥−0.2 L. Analyses of other pulmonary function tests, patient reported outcomes, rescue medication use, asthma exacerbations and quality of life questionnaires were also comparable. The safety profiles of the two study groups were similar overall.Conclusions:Fluticasone/formoterol combination therapy had comparable efficacy to its individual components administered concurrently, when measured by post-dose FEV1 in patients aged ≥12 years with mild to moderate–severe asthma. The safety and tolerability profile of fluticasone/formoterol combination therapy was similar to that of its individual components administered concurrently. Although this was an open-label study, the results remain compelling: the primary efficacy measure was a physical endpoint and study statisticians were blinded to treatment allocations until analysis was completed.Trial registration:EudraCT: 2007-001634-13; US NCT number: NCT00563056." @default.
- W1989553661 created "2016-06-24" @default.
- W1989553661 creator A5006699282 @default.
- W1989553661 creator A5019552605 @default.
- W1989553661 creator A5050091624 @default.
- W1989553661 creator A5082981501 @default.
- W1989553661 creator A5089027757 @default.
- W1989553661 date "2013-02-20" @default.
- W1989553661 modified "2023-09-27" @default.
- W1989553661 title "Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial" @default.
- W1989553661 cites W1968405264 @default.
- W1989553661 cites W2003706075 @default.
- W1989553661 cites W2009200551 @default.
- W1989553661 cites W2053351348 @default.
- W1989553661 cites W2072039353 @default.
- W1989553661 cites W2082273266 @default.
- W1989553661 cites W2082690625 @default.
- W1989553661 cites W2100197717 @default.
- W1989553661 cites W2115012618 @default.
- W1989553661 cites W2125078269 @default.
- W1989553661 cites W2127481776 @default.
- W1989553661 cites W2161390117 @default.
- W1989553661 cites W2166915032 @default.
- W1989553661 cites W2994597783 @default.
- W1989553661 doi "https://doi.org/10.1185/03007995.2013.772506" @default.
- W1989553661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23368897" @default.
- W1989553661 hasPublicationYear "2013" @default.
- W1989553661 type Work @default.
- W1989553661 sameAs 1989553661 @default.
- W1989553661 citedByCount "32" @default.
- W1989553661 countsByYear W19895536612013 @default.
- W1989553661 countsByYear W19895536612014 @default.
- W1989553661 countsByYear W19895536612015 @default.
- W1989553661 countsByYear W19895536612016 @default.
- W1989553661 countsByYear W19895536612017 @default.
- W1989553661 countsByYear W19895536612018 @default.
- W1989553661 countsByYear W19895536612019 @default.
- W1989553661 countsByYear W19895536612020 @default.
- W1989553661 countsByYear W19895536612021 @default.
- W1989553661 countsByYear W19895536612022 @default.
- W1989553661 countsByYear W19895536612023 @default.
- W1989553661 crossrefType "journal-article" @default.
- W1989553661 hasAuthorship W1989553661A5006699282 @default.
- W1989553661 hasAuthorship W1989553661A5019552605 @default.
- W1989553661 hasAuthorship W1989553661A5050091624 @default.
- W1989553661 hasAuthorship W1989553661A5082981501 @default.
- W1989553661 hasAuthorship W1989553661A5089027757 @default.
- W1989553661 hasConcept C126322002 @default.
- W1989553661 hasConcept C2776042228 @default.
- W1989553661 hasConcept C2776136866 @default.
- W1989553661 hasConcept C2779028295 @default.
- W1989553661 hasConcept C2779871671 @default.
- W1989553661 hasConcept C2780261241 @default.
- W1989553661 hasConcept C2781212218 @default.
- W1989553661 hasConcept C2909086917 @default.
- W1989553661 hasConcept C42219234 @default.
- W1989553661 hasConcept C71924100 @default.
- W1989553661 hasConcept C98274493 @default.
- W1989553661 hasConceptScore W1989553661C126322002 @default.
- W1989553661 hasConceptScore W1989553661C2776042228 @default.
- W1989553661 hasConceptScore W1989553661C2776136866 @default.
- W1989553661 hasConceptScore W1989553661C2779028295 @default.
- W1989553661 hasConceptScore W1989553661C2779871671 @default.
- W1989553661 hasConceptScore W1989553661C2780261241 @default.
- W1989553661 hasConceptScore W1989553661C2781212218 @default.
- W1989553661 hasConceptScore W1989553661C2909086917 @default.
- W1989553661 hasConceptScore W1989553661C42219234 @default.
- W1989553661 hasConceptScore W1989553661C71924100 @default.
- W1989553661 hasConceptScore W1989553661C98274493 @default.
- W1989553661 hasIssue "5" @default.
- W1989553661 hasLocation W19895536611 @default.
- W1989553661 hasLocation W19895536612 @default.
- W1989553661 hasOpenAccess W1989553661 @default.
- W1989553661 hasPrimaryLocation W19895536611 @default.
- W1989553661 hasRelatedWork W1419949864 @default.
- W1989553661 hasRelatedWork W1973173772 @default.
- W1989553661 hasRelatedWork W1989553661 @default.
- W1989553661 hasRelatedWork W1990444499 @default.
- W1989553661 hasRelatedWork W2003706075 @default.
- W1989553661 hasRelatedWork W2032558045 @default.
- W1989553661 hasRelatedWork W2057543685 @default.
- W1989553661 hasRelatedWork W2080945474 @default.
- W1989553661 hasRelatedWork W2097738211 @default.
- W1989553661 hasRelatedWork W2154436876 @default.
- W1989553661 hasVolume "29" @default.
- W1989553661 isParatext "false" @default.
- W1989553661 isRetracted "false" @default.
- W1989553661 magId "1989553661" @default.
- W1989553661 workType "article" @default.